This HTML5 document contains 176 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168935/price-of-originator/
n19	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n8	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168935/reimbursement/
n3	http://linked.opendata.cz/ontology/sukl/
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168935/
n12	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168935/core-reimbursement/
n5	http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/002404/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0168935/price/
skos	http://www.w3.org/2004/02/skos/core#
n20	http://linked.opendata.cz/resource/sukl/indgroup/
n11	http://linked.opendata.cz/resource/sukl/packing/
n14	http://linked.opendata.cz/resource/sukl/company/
n18	http://linked.opendata.cz/resource/sukl/active-ingredient/
n10	http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n17	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n13	http://linked.opendata.cz/resource/sukl/df/
n6	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0168935

rdf:type

n3:MedicinalProductPackaging

dcterms:title

DESLORATADINE RATIOPHARM 5 MG

skos:notation

0168935

n3:hasATCCode

n6:R06AX27

n3:hasActiveIngredient

n18:DESLORATADINUM

n3:hasDefinedDailyDose

n9:ddd

n3:hasDosageForm

n13:TBL-FLM-POR

n3:hasPackagingSize

30

n3:hasPacking

n11:BLI

n3:hasRegistrationHolder

n14:RATD

n3:hasRegistrationState

n17:R

n3:hasRouteOfAdministration

n19:POR

n3:hasStrength

5MG

n3:hasIndicationGroup

n20:24

n3:hasSpecializationRestriction

n10:blank-cell

n3:containsDefinedDailyDoses

30.0

n3:hasRegistrationCode

EU/1/11/746/006

n3:hasTitleSupplement

POR TBL FLM 30X5MG

n3:containsUsualTherapeuticalDailyDoses

30

n3:hasBreakMarketingDate

2013-06-18+02:00

n3:hasCoreReimbursementSpecification

n12:2015-01-13 n12:2015-02-01 n12:2014-12-01 n12:2015-01-01 n12:2015-04-02 n12:2015-05-01 n12:2015-03-01 n12:2015-04-01 n12:2015-06-01 n12:2014-02-01 n12:2014-03-01 n12:2013-12-01 n12:2014-01-01 n12:2014-06-01 n12:2014-06-13 n12:2014-04-01 n12:2014-05-01 n12:2014-08-01 n12:2014-09-01 n12:2014-07-01 n12:2014-07-03 n12:2014-11-01 n12:2014-11-19 n12:2014-10-01 n12:2014-10-02 n12:2013-01-01 n12:2013-03-01 n12:2013-04-01 n12:2013-01-05 n12:2013-02-01 n12:2013-07-01 n12:2013-08-01 n12:2013-05-01 n12:2013-06-01 n12:2013-10-01 n12:2013-11-01 n12:2013-08-03 n12:2013-09-01

n3:hasPriceOfOriginatorSpecification

n15:2014-07-01 n15:2014-07-03 n15:2014-06-01 n15:2014-06-13 n15:2014-04-01 n15:2014-05-01 n15:2014-02-01 n15:2014-03-01 n15:2013-12-01 n15:2014-01-01 n15:2013-10-01 n15:2013-11-01 n15:2013-08-03 n15:2013-09-01 n15:2013-07-01 n15:2013-08-01 n15:2015-06-01 n15:2015-04-02 n15:2015-05-01 n15:2015-03-01 n15:2015-04-01 n15:2015-01-13 n15:2015-02-01 n15:2014-12-01 n15:2015-01-01 n15:2014-11-01 n15:2014-11-19 n15:2014-10-01 n15:2014-10-02 n15:2014-08-01 n15:2014-09-01 n15:2013-05-01 n15:2013-06-01 n15:2013-03-01 n15:2013-04-01 n15:2013-01-05 n15:2013-02-01 n15:2013-01-01

n3:hasPriceSpecification

n4:2013-12-01 n4:2014-01-01 n4:2014-02-01 n4:2014-03-01 n4:2013-01-05 n4:2013-02-01 n4:2013-03-01 n4:2013-04-01 n4:2013-05-01 n4:2013-06-01 n4:2013-07-01 n4:2013-08-01 n4:2014-10-01 n4:2014-10-02 n4:2014-11-01 n4:2014-11-19 n4:2014-12-01 n4:2015-01-01 n4:2015-01-13 n4:2015-02-01 n4:2014-04-01 n4:2014-05-01 n4:2014-06-01 n4:2014-06-13 n4:2014-07-01 n4:2014-07-03 n4:2014-08-01 n4:2014-09-01 n4:2013-01-01 n4:2015-03-01 n4:2015-04-01 n4:2015-04-02 n4:2015-05-01 n4:2015-06-01 n4:2013-08-03 n4:2013-09-01 n4:2013-10-01 n4:2013-11-01

n3:hasReimbursementSpecification

n8:2015-06-01 n8:2015-04-02 n8:2015-05-01 n8:2014-12-01 n8:2015-01-01 n8:2014-11-01 n8:2014-11-19 n8:2015-03-01 n8:2015-04-01 n8:2015-01-13 n8:2015-02-01 n8:2013-05-01 n8:2013-06-01 n8:2013-03-01 n8:2013-04-01 n8:2013-08-03 n8:2013-09-01 n8:2013-07-01 n8:2013-08-01 n8:2013-01-05 n8:2013-02-01 n8:2013-01-01 n8:2014-07-01 n8:2014-07-03 n8:2014-06-01 n8:2014-06-13 n8:2014-10-01 n8:2014-10-02 n8:2014-08-01 n8:2014-09-01 n8:2013-12-01 n8:2014-01-01 n8:2013-10-01 n8:2013-11-01 n8:2014-04-01 n8:2014-05-01 n8:2014-02-01 n8:2014-03-01

n3:hasResumedMarketingDate

2012-07-23+02:00

n3:hasUsualTherapeuticalDailyDose

n9:utdd

n3:spcFile

http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F002404%2FWC500122415.pdf

n3:spcUri

n5:WC500122415.pdf